文献速递神经肿瘤

分子定义的弥漫性低级别胶质瘤切除程度的当代评估:体积分析

Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis.
PubMed 文献 · J Neurosurg · 2019-10-25

该回顾性分析纳入326例在布列根和妇女医院及麻省总医院(2000-2017年)手术的半球WHO II级弥漫性低级别胶质瘤患者,体积法计算切除程度。术后残留体积增加与总生存、无进展生存和恶性进展无进展生存更差相关,该效应在IDH突变型和IDH野生型星形细胞瘤中更明显,少突胶质细胞瘤残留超过8 cm³才影响生存。

要点

  • 术后残留体积每增加1 cm³,总生存HR 1.02(95%CI 1.00-1.03;p=0.016)。
  • IDH突变型和IDH野生型星形细胞瘤中,残留仅1 cm³即见生存差异。
  • 少突胶质细胞瘤患者术后残留超过8 cm³才影响生存。

核心结论

  • 结果证实切除程度在所有分子亚型弥漫性低级别胶质瘤中对生存和恶性转化均有作用。
  • IDH突变型和IDH野生型星形细胞瘤即使微小术后残留也受影响,患者可能从更积极的手术方式中获益。

研究设计与样本

  • 回顾性分析326例在布列根和妇女医院及麻省总医院(2000-2017年)因半球WHO II级低级别胶质瘤接受手术的患者。
  • 切除程度通过体积法计算,并构建Cox比例风险模型评估总生存、无进展生存和恶性进展无进展生存的预测因素。

主要发现

  • 326例患者中43例死亡(13.2%;中位随访5.4年)。
  • 术前肿瘤体积中位数31.2 cm³(IQR 12.9-66.0),术后残留肿瘤体积中位数5.8 cm³(IQR 1.1-20.5)。
  • 多变量Cox回归中,术后体积增加与总生存更差相关(HR 1.02/cm³;95%CI 1.00-1.03;p=0.016),与无进展生存更差相关(HR 1.01/cm³;95%CI 1.00-1.02;p=0.001),与恶性进展无进展生存更差相关(HR 1.01/cm³;95%CI 1.00-1.02;p=0.035)。
  • 该结果在预后较差的IDH突变型和IDH野生型星形细胞瘤亚型中更明显,残留肿瘤体积仅1 cm³即出现生存差异;少突胶质细胞瘤患者术后残留超过8 cm³才影响生存。
  • 总生存的其他显著预测因素包括诊断时年龄、IDH突变型和IDH野生型星形细胞瘤分类、辅助放疗以及术前体积增加。

临床怎么用

  • 作者认为IDH突变型和IDH野生型星形细胞瘤患者可能从更积极的手术方式中获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While the effect of increased extent of resection (EOR) on survival in diffuse infiltrating low-grade glioma (LGG) patients is well established, there is still uncertainty about the influence of the new WHO molecular subtypes. The authors designed a retrospective analysis to assess the interplay between EOR and molecular classes. METHODS: The authors retrospectively reviewed the records of 326 patients treated surgically for hemispheric WHO grade II LGG at Brigham and Women's Hospital and Massachusetts General Hospital (2000-2017). EOR was calculated volumetrically and Cox proportional hazards models were built to assess for predictive factors of overall survival (OS), progression-free survival (PFS), and malignant progression-free survival (MPFS). RESULTS: There were 43 deaths (13.2%; median follow-up 5.4 years) among 326 LGG patients. Median preoperative tumor volume was 31.2 cm3 (IQR 12.9-66.0), and median postoperative residual tumor volume was 5.8 cm3 (IQR 1.1-20.5). On multivariable Cox regression, increasing postoperative volume was associated with worse OS (HR 1.02 per cm3; 95% CI 1.00-1.03; p = 0.016), PFS (HR 1.01 per cm3; 95% CI 1.00-1.02; p = 0.001), and MPFS (HR 1.01 per cm3; 95% CI 1.00-1.02; p = 0.035). This result was more pronounced in the worse prognosis subtypes of IDH-mutant and IDH-wildtype astrocytoma, for which differences in survival manifested in cases with residual tumor volume of only 1 cm3. In oligodendroglioma patients, postoperative residuals impacted survival when exceeding 8 cm3. Other significant predictors of OS were age at diagnosis, IDH-mutant and IDH-wildtype astrocytoma classes, adjuvant radiotherapy, and increasing preoperative volume. CONCLUSIONS: The results corroborate the role of EOR in survival and malignant transformation across all molecular subtypes of diffuse LGG. IDH-mutant and IDH-wildtype astrocytomas are affected even by minimal postoperative residuals and patients could potentially benefit from a more aggressive surgical approach.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kavouridis VK, Boaro A, Dorr J, et al. Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis. J Neurosurg. 2019. PMID: 31653812. doi:10.3171/2019.6.JNS19972

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。